| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.01B | +8.3% |
| Cost of Revenue | $638.7M | +7.5% |
| Gross Profit | $374.8M | +9.6% |
| R&D Expense | $26.2M | +25.1% |
| SG&A Expense | $106.8M | +12.6% |
| Operating Income | $107.1M | +9.5% |
| Interest Expense | $38.0M | +35.8% |
| Pre-tax Income | $61.5M | -17.4% |
| Income Tax | $14.9M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $114.1M | -14.3% |
| Accounts Receivable | $171.2M | +13.0% |
| Inventory | $186.1M | +3.8% |
| Current Assets | $514.2M | +3.6% |
| Total Assets | $1.83B | +7.5% |
| Current Liabilities | $261.8M | +8.3% |
| Long-term Debt | $517.3M | +12.9% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $67.2M | -19.7% |
| Capital Expenditures | $24.8M | +96.4% |
| Investing Cash Flow | -$133.4M | -857.2% |
| Financing Cash Flow | $48.2M | +196.4% |
| Free Cash Flow | $42.4M | -40.3% |
| -42.8% |
| Net Income | $46.6M | -3.7% |
| EPS (Basic) | $1.62 | -4.1% |
| EPS (Diluted) | $1.61 | -4.2% |
| Total Liabilities |
| $943.9M |
| +9.2% |
| Stockholders' Equity | $882.1M | +5.8% |